Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity
暂无分享,去创建一个
Xiaowei Zhan | L. Hooper | C. Pasare | Laura A. Coughlin | Jiwoong Kim | A. Koh | Bret M. Evers | Yajing Gao | J. Lichterman | Yongbin Choi | Nicole Poulides | Wenling Li | Priscilla Del Valle | Suzette N. Palmer | Shuheng Gan
[1] R. Weissleder,et al. Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12. , 2022, Immunity.
[2] T. D. de Gruijl,et al. Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation , 2022, Science Immunology.
[3] R. Rodrigues,et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment , 2021, Cell.
[4] M. Konopleva,et al. Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy , 2021, Blood advances.
[5] Juliel Espinosa,et al. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy , 2021, Science.
[6] G. Zeller,et al. Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors. , 2021, Cell host & microbe.
[7] T. Cloughesy,et al. Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma , 2021, Nature Communications.
[8] M. Hurwitz,et al. Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma , 2021, Journal of Clinical Oncology.
[9] T. Lawrence,et al. NF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity , 2021, Science Immunology.
[10] C. Mackay,et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. , 2021, Cell metabolism.
[11] J. Badger,et al. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients , 2021, Science.
[12] N. Ajami,et al. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade , 2020, Nature Medicine.
[13] N. Ajami,et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients , 2020, Science.
[14] Z. Szallasi,et al. Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage , 2020, Science.
[15] K. McCoy,et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy , 2020, Science.
[16] Noam Shental,et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.
[17] M. Suarez‐Almazor,et al. Immune-related adverse events of checkpoint inhibitors , 2020, Nature Reviews Disease Primers.
[18] J. Farkas. Immune-related adverse events of checkpoint inhibitors , 2020, Nature Reviews Disease Primers.
[19] Rob Knight,et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach , 2020, Nature.
[20] J. Gommerman,et al. Dendritic Cell Subsets in Intestinal Immunity and Inflammation , 2020, The Journal of Immunology.
[21] B. Comin-Anduix,et al. Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist , 2020, Nature Communications.
[22] E. Wakeland,et al. Transcriptional profiling identifies caspase-1 as a T cell–intrinsic regulator of Th17 differentiation , 2020, The Journal of experimental medicine.
[23] D. Altmann,et al. Antibiotic therapy and outcome from immune-checkpoint inhibitors , 2019, Journal of Immunotherapy for Cancer.
[24] D. Goodlett,et al. The Role of TLRs in Anti-cancer Immunity and Tumor Rejection , 2019, Front. Immunol..
[25] C. Brock,et al. Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer. , 2019, JAMA oncology.
[26] S. Turner,et al. Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8+ T Cells. , 2019, Immunity.
[27] M. Gilmore,et al. Mechanisms and consequences of gut commensal translocation in chronic diseases , 2019, Gut microbes.
[28] V. Badovinac,et al. Cutting Edge: Polymicrobial Sepsis Has the Capacity to Reinvigorate Tumor-Infiltrating CD8 T Cells and Prolong Host Survival , 2019, The Journal of Immunology.
[29] E. Ruppin,et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice , 2019, Nature Communications.
[30] K. Bélanger,et al. Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors , 2019, Oncoimmunology.
[31] K. Crozat,et al. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How? , 2019, Front. Immunol..
[32] Amy Holt,et al. The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant , 2019, Scientific Reports.
[33] D. Schadendorf,et al. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. , 2019, The New England journal of medicine.
[34] Ralph Weissleder,et al. Successful Anti‐PD‐1 Cancer Immunotherapy Requires T Cell‐Dendritic Cell Crosstalk Involving the Cytokines IFN‐&ggr; and IL‐12 , 2018, Immunity.
[35] A. Chan,et al. Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report , 2018, Case Reports in Oncology.
[36] L. Massuger,et al. Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case Report , 2018, Front. Oncol..
[37] N. Salzman,et al. Ceftriaxone Administration Disrupts Intestinal Homeostasis, Mediating Noninflammatory Proliferation and Dissemination of Commensal Enterococci , 2018, Infection and Immunity.
[38] Alaina Kaiser,et al. Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL. , 2018, Blood.
[39] Kaushal Parikh,et al. Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors , 2018, Oncoimmunology.
[40] T. Colpitts,et al. Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response , 2018, The Journal of Immunology.
[41] S. Loi,et al. Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells , 2018, Cancer Immunology Research.
[42] L. Zitvogel,et al. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[43] Konomi Ohshio,et al. Characterization of genomic DNA of lactic acid bacteria for activation of plasmacytoid dendritic cells , 2018, bioRxiv.
[44] Laurence Zitvogel,et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors , 2018, Science.
[45] E. Le Chatelier,et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients , 2018, Science.
[46] Riyue Bao,et al. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients , 2018, Science.
[47] E. Frenkel,et al. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients , 2017, Neoplasia.
[48] A. Eggermont,et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[49] T. Gajewski,et al. Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. , 2017, Cancer cell.
[50] Zhijian J. Chen,et al. cGAS is essential for the antitumor effect of immune checkpoint blockade , 2017, Proceedings of the National Academy of Sciences.
[51] Scott N. Mueller,et al. Infection Programs Sustained Lymphoid Stromal Cell Responses and Shapes Lymph Node Remodeling upon Secondary Challenge. , 2017, Cell reports.
[52] P. Rosenstiel,et al. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. , 2016, Immunity.
[53] Matthieu Texier,et al. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination , 2016, Nature Reviews Clinical Oncology.
[54] B. Hall,et al. Tumor Induced Stromal Reprogramming Drives Lymph Node Transformation , 2016, Nature Immunology.
[55] G. Núñez,et al. Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. , 2016, Immunity.
[56] F. Ginhoux,et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota , 2015, Science.
[57] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[58] M. Valsecchi. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. , 2015, The New England journal of medicine.
[59] Xiaowei Zhan,et al. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization , 2015, Nature Medicine.
[60] Xiu-chun Yu,et al. Postoperative infection and survival in osteosarcoma patients: Reconsideration of immunotherapy for osteosarcoma. , 2015, Molecular and clinical oncology.
[61] G. Reynolds,et al. Dendritic Cell Maturation and Survival Are Differentially Regulated by TNFR1 and TNFR2 , 2014, The Journal of Immunology.
[62] Taro Kawai,et al. Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..
[63] Eric Vivier,et al. The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide , 2013, Science.
[64] Jaykaran Charan,et al. How to calculate sample size in animal studies? , 2013, Journal of pharmacology & pharmacotherapeutics.
[65] D. Littman,et al. Microbiota Restrict Trafficking of Bacteria to Mesenteric Lymph Nodes by CX3CR1hi Cells , 2013, Nature.
[66] R. Vance,et al. Lethal inflammasome activation by a multi-drug resistant pathobiont upon antibiotic disruption of the microbiota , 2012, Nature Medicine.
[67] L. Peyrin-Biroulet,et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease , 2011, Gut.
[68] N. Socci,et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. , 2010, The Journal of clinical investigation.
[69] U. Hobohm,et al. Pathogen-associated molecular pattern in cancer immunotherapy. , 2008, Critical reviews in immunology.
[70] A. Ruddell,et al. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. , 2007, The American journal of pathology.
[71] R. Steinman,et al. Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.
[72] E. Ekland,et al. Regulation of lymph node vascular growth by dendritic cells , 2006, The Journal of experimental medicine.
[73] R. Mebius. Faculty Opinions recommendation of B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. , 2006 .
[74] A. Macpherson,et al. Mesenteric lymph nodes at the center of immune anatomy , 2006, The Journal of experimental medicine.
[75] F. Ginhoux,et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. , 2006, Immunity.
[76] H. Kiyono,et al. CCR7 Is Critically Important for Migration of Dendritic Cells in Intestinal Lamina Propria to Mesenteric Lymph Nodes1 , 2006, The Journal of Immunology.
[77] M. Festing. Design and statistical methods in studies using animal models of development. , 2006, ILAR journal.
[78] C. A. Kuntz,et al. Improved Survival Associated With Postoperative Wound Infection in Dogs Treated With Limb-Salvage Surgery for Osteosarcoma , 2005, Annals of Surgical Oncology.
[79] Jianping Pan,et al. Interferon-γ is an autocrine mediator for dendritic cell maturation , 2004 .
[80] A. Macpherson,et al. Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria , 2004, Science.
[81] U. Höpken,et al. The chemokine receptor CCR7 controls lymph node‐dependent cytotoxic T cell priming in alloimmune responses , 2004, European journal of immunology.
[82] J. Aitchison,et al. Biplots of Compositional Data , 2002 .
[83] Steffen Jung,et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.
[84] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[85] A. Galy,et al. IL-1β induces dendritic cells to produce IL-12 , 2001 .
[86] D. C. Henckel,et al. Case report. , 1995, Journal.
[87] Scott F. Smith,et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. , 1994, Science.
[88] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.
[89] J. Delaney,et al. Abdominal radiation causes bacterial translocation. , 1989, The Journal of surgical research.
[90] S. Schantz,et al. Improved Survival Associated with Postoperative Wound Infection in Laryngeal Cancer: An Analysis of Its Therapeutic Implications , 1980, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.